Fidelity SPDR Advertisement
Home > Boards > US OTC > Delisted > Michelex Corp (fka MLXO)

"Last week, pursuant to conversations with staff of

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
harr449 Member Profile
Member Level 
Followed By 50
Posts 23,660
Boards Moderated 2
Alias Born 12/19/04
160x600 placeholder
Roche Hit By Failure Of Cancer Drug Trial
Roche said a late-stage study of its breast cancer drug Kadcyla failed to yield superior results to an existing treatment, damaging the outlook for stronger sales in one of its key drug markets.
More Top Equities Stories Of The Day
Deezer Names New CEO Before Full U.S. Launch
Whistleblowers Score a Big Payday -- Update
Mobile's Rise Poses a Riddle for Banks
AT&T Boosts Dividend
U.S. Hot Stocks: Hot Stocks to Watch
Brazilian Shares Rise, Led by Rossi Residencial; Real Weakens Slightly
Oracle Beats Street View for First Time in a Year
Alstom CEO Expects to Settle DOJ Bribery Allegations Very Soon
harr449 Member Level  Thursday, 05/24/12 08:52:47 AM
Re: harr449 post# 33550
Post # of 35710 
"Last week, pursuant to conversations with staff of the Securities and Exchange Commission, Michelex Corporation notified the SEC via fax and letter that Michelex will submit all filings required under Section 13(a) of the Securities Exchange Act of 1934 to the Securities and Exchange Commission on, or before, August 31, 2012".

http://michelex.com/html/index.aspx?p32sda=news&psdge87d=204&tl97abi=42&nsd=35




Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist